Jason Taule

Jason Taule

Maryland Innovation Center
CISO-In-Residence and Cyber Advisory Council Chair

Jason Taule is a 30-year information assurance and cybersecurity veteran who has worked in both the intelligence community and commercial sectors first consulting to Federal agencies and then serving as inside CISO and CPO both within the Government and at large systems integrators like General Dynamics and CSC.
Mr. Taule helped build the original DARPA CERT, helped develop the first computer security programs at the VA and NASA, and revised the Risk Assessment Methodology still used throughout DHHS. Mr. Taule helped author the Maryland Data Privacy Law, led a multi-million-dollar global cyber security practice for a large international consulting firm, ran the team responsible for HIPAA complaint investigations for OCR for 3 years, and for the last 20 years has been a luminary in the US Health IT sector helping hundreds of systems earn their accreditations and avoid compromise.
Mr. Taule currently serves as the Cyber Advisory Council Chair and CISO-In-Residence of the Maryland Innovation Center (MIC), an advanced business incubator helping companies in the greater Washington-Baltimore metroplex start and grow. In this capacity, Mr. Taule helps companies fulfill information protection and compliance requirements upon which access to customers and capital depends.
Mr. Taule holds a Masters in IT Management from Johns Hopkins University and a BBA from the College of William and Mary. Mr. Taule holds numerous certifications, is a graduate of the FBI Citizen’s Academy, is member of the Homeland Security Preparation and Response Team, serves on the Board of the Loyola Sellinger School of Business, and is a founding member / National Advisor to the CISO Executive Network. Mr. Taule sits on the DHHS/CMS Information Security & Privacy Workgroup, the FBI Cyber Health Work Group, the US Health IT Standards Committee’s Transport and Security Workgroup and is a White House invitee to the Security Policy Roundtable for the President’s Precision Medicine Initiative.

prestitial ad